ER positive	Estrogen Receptor Positive Breast Cancer	ER positive	Estrogen Receptor Positive Breast Cancer	fulvestrant Sensitive: A1 - Approval fulvestrant Sensitive : A1	fulvestrant Sensitive: A1 - Approval fulvestrant Sensitive : A1
ER positive	Estrogen Receptor Positive Breast Cancer	ER positive	Estrogen Receptor Positive Breast Cancer	exemestane Sensitive: A1 - Approval exemestane Sensitive : A1	exemestane Sensitive: A1 - Approval exemestane Sensitive : A1
ER positive	Estrogen Receptor Positive Breast Cancer	ER positive	Estrogen Receptor Positive Breast Cancer	toremifene Sensitive: A1 - Approval toremifene Sensitive : A1	toremifene Sensitive: A1 - Approval toremifene Sensitive : A1
ER positive	Estrogen Receptor Positive Breast Cancer	ER positive	Estrogen Receptor Positive Breast Cancer	goserelin acetate Sensitive: A1 - Approval goserelin acetate Sensitive : A1	goserelin acetate Sensitive: A1 - Approval goserelin acetate Sensitive : A1
ER mutation	Estrogen Receptor Positive Breast Cancer	ER mutation	Estrogen Receptor Positive Breast Cancer	palbociclib Sensitive: B - Late Trials palbociclib Sensitive : B	palbociclib Sensitive: B - Late Trials palbociclib Sensitive : B
ER positive	Estrogen Receptor Positive Breast Cancer	ER positive	Estrogen Receptor Positive Breast Cancer	palbociclib Sensitive: B - Late Trials palbociclib Sensitive : B	palbociclib Sensitive: B - Late Trials palbociclib Sensitive : B
ER mutation	Estrogen Receptor Positive Breast Cancer	ER mutation	Estrogen Receptor Positive Breast Cancer	fulvestrant Sensitive: B - Late Trials fulvestrant Sensitive : B	fulvestrant Sensitive: B - Late Trials fulvestrant Sensitive : B
ER mutation	Estrogen Receptor Positive Breast Cancer	ER mutation	Estrogen Receptor Positive Breast Cancer	exemestane Resistant: B - Late Trials exemestane Resistant : B	exemestane Resistant: B - Late Trials exemestane Resistant : B
HSD17B2 overexpression	Estrogen Receptor Positive Breast Cancer	HSD17B2 overexpression	Estrogen Receptor Positive Breast Cancer	tamoxifen Sensitive: B - Late Trials tamoxifen Sensitive : B	tamoxifen Sensitive: B - Late Trials tamoxifen Sensitive : B
IGFBP7 overexpression	Estrogen Receptor Positive Breast Cancer	IGFBP7 overexpression	Estrogen Receptor Positive Breast Cancer	tamoxifen Sensitive: B - Late Trials tamoxifen Sensitive : B	tamoxifen Sensitive: B - Late Trials tamoxifen Sensitive : B
ER positive	Estrogen Receptor Positive Breast Cancer	ER positive	Estrogen Receptor Positive Breast Cancer	elacestrant Sensitive: B - Late Trials elacestrant Sensitive : B	elacestrant Sensitive: B - Late Trials elacestrant Sensitive : B
ESR1 mutation	Estrogen Receptor Positive Breast Cancer	ESR1 mutation	Estrogen Receptor Positive Breast Cancer	palbociclib Sensitive: B - Late Trials palbociclib Sensitive : B	palbociclib Sensitive: B - Late Trials palbociclib Sensitive : B

Estrogen Receptor Positive Breast Cancer

Associations(221)

Associations
(221)